PMA induces vaccine adjuvant activity by the modulation of TLR signaling pathway.
Toll-like receptors (TLRs) play crucial roles in innate immunity and can contribute to the development of appropriate adaptive immune responses [1, 2]. To date, 13 members of TLR family have been identified in mammals [3-5], and TLRs received special attention as potent adjuvant receptors . Mammalian TLR5, expressed on epithelial cells and phagocytes such as dendritic cells and macrophages, recognizes flagellins of bacteria and subsequently activates the nuclear factor-kappa B (NF-[kappa]B) pathway of host cells [7, 8]. We reported that a Vibrio vulnificus flagellin B (FlaB) showed strong mucosal vaccine adjuvant activity  and enhanced tumor-specific [CD8.sup.+] T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model . Recently, FlaB combined with TNF[alpha] and IFN[alpha] was reported to generate potent dendritic cells which produce functionally active cytotoxic T lymphocytes .
Flagellin is a highly priced protein adjuvant candidate. To identify ligands that potentiate vaccine adjuvant activity of flagellin, we screened a plant extract library using HEK293T cells transiently cotransfected with phTLR5 and pNF-[kappa]B-SEAP plasmids. The 90% EtOH extract from Croton tiglium L. (Euphorbiaceae) showed significant NF-[kappa]B transactivation. Croton tiglium is a plant grown in tropical and subtropical zones, and the seed of Croton tiglium is well known as BaDou (or Badou) in China and Korea. Ba-Dou has been used to treat gastrointestinal disorders, intestinal inflammation, rheumatism, headache, peptic ulcer, and visceral pain [12-14]. The sesquiterpenes and monoterpenes as the main components comprise the great parts of the extracted essential oil from seed. The toxic substances were found mainly in the bark and leaves of Croton tiglium and croton oil. In this study, we isolated phorbol 12-myristate 13-acetate (PMA) as an active component from Croton tiglium and investigated the action mechanisms in TLR signaling pathways.
2. Materials and Methods
2.1. Cell Culture. HEK293T and Caco-2 cells (ATCC, Manassas, VA) were cultured in Dulbecco modified Eagle medium (DMEM, WELGENE, Korea) supplemented with 10% fetal bovine serum (FBS, GIBCO, Invitrogen, Carlsbad, CA) at 37[degrees]C in a 5% C[O.sub.2] incubator.
2.2. NF-[kappa]B ReporterAssay. HEK293T cell is a human embryonic kidney cell line with SV40 large T-antigen for efficient transfection of plasmids. HEK293T cells seeded at 104/well in 96-well plates were transfected with pNF-[kappa]B-secreted alkaline phosphatase (pNF-[kappa]B-SEAP, InvivoGen, San Diego, California), pIL-8-luciferase , or phTLR5 plasmids using Fugene 6 (Roche, Hague Road, Indianapolis). One day after transfection, the cells were replaced with fresh DMEM containing different concentrations of test agents for 1 day. NF-[kappa]B-SEAP activities in cell culture supernatants were determined using QUANTI-Blue (InvivoGen) according to the manufacturer's instructions. Recombinant tag-free flagellin, FlaB, was purified as described elsewhere and contaminating lipopolysaccharide (LPS) was removed by using the Affinity-Pak Detoxi Gel endotoxin removing gel (Pierce Biotechnology, Inc., Rockford, IL) .
2.3. Plant Materials. The seeds of Croton tiglium were purchased from Chonnam Seangyack Nongob, Hwasun-gun, in April 2011, Republic of Korea. Plant sample was identified botanically by Professor Y. H. Moon. A voucher specimen (SNU2011-04) was deposited at the Herbarium of Seoul National University, Seoul, Republic of Korea.
2.4. Extraction and Isolation from the Seeds of Croton tiglium. The dried seeds of Croton tiglium (600 g) were extracted with 90% EtOH (2 L x 3 times) at room temperature. The combined 90% EtOH extract was then evaporated under reduced pressure using a rotary vacuum evaporator (EYELA, Japan). The dried crude extract of Croton tiglium (12 g) was suspended in water and divided successively with n-hexane (3 x 500 mL), CH[Cl.sub.3] (3 x 500 mL), EtOAc (3 x 500 mL), and n-BuOH (3 x 500 mL). The CH[Cl.sub.3] fraction (2.9 g), which showed strong enhanced activity on NF-[kappa]B transcription, was chromatographed over a silica gel open column (5 x 40 cm; 63-200 [micro]m particle size, Merck, Darmstadt, Germany) eluting with gradient n-hexane/acetone (20: 1,10: 1, ..., 1: 3, each 200 mL) to yield ten fractions (F1-F10) based on the TLC profile. Fraction F8 (1.05 g) was reapplied to an RP-[C.sub.18] open column (4 x 30 cm; 40-63 [micro]m particle size) with a stepwise gradient of MeOH/[H.sub.2]O (1:2 to 10:1) to afford nine subfractions (F81-F89). Finally, subfraction F87 (30.2 mg) was purified by HPLC [OptimaPak [C.sub.18] column (10 x 250 mm, 10 [micro]m particle size, RS Tech, Korea); mobile phase MeOH in [H.sub.2]O containing 0.1% HC[O.sub.2]H (0-15 min: 85% MeOH, 15-40min: 95% MeOH, 40-45min: 100% MeOH)] to yield compound 1 ([t.sub.R] = 31.3 min, 5.2 mg) (Figure 2).
2.5. IL-8 ELISA in Caco-2 Cells. Caco-2 is a heterogeneous human epithelial colorectal adenocarcinoma cell and constituently expresses TLR5. Caco-2 cells were seeded at 5 x [10.sup.4]/well in 48-well plates and were treated with ligands for 8 hours without FBS supplementation. IL-8 in the supernatant was measured by an ELISA kit (BioSource International, Inc., California, USA) according to the manufacturer's instructions.
2.6. Cell Staining and Fluorescence Microscopy. HEK293T cells in 8-well glass chamber plate (Nalge Nunc International, Rochester, NY) were transfected with phTLR5 using Fugene 6 (Roche). The cell culture was replaced with fresh DMEM containing PMA for 6 hours. After fixation for 15 minutes with 3.7% paraformaldehyde, the cells were rendered permeable by incubation in PBS with 0.2% Triton X-100 for 10 minutes. NF-[kappa]B p65 protein was detected by immunostaining using a specific antibody (Santa Cruz Biotechnology, Delaware Avenue, Santa Cruz, CA) and Alexa Fluor-488-conjugated anti-rabbit-IgG antibody (Molecular Probes, Invitrogen, Eugene, OR). Fluorescence images were acquired using a fluorescence microscope (DXM1200C, Nikon).
2.7. Inhibition Assay of Pharmacological Antagonists on PMA-Induced NF-[kappa]B Activity. To study the action mechanism, various pharmacological inhibitors were tested on PMA-mediated NF-[kappa]B activation. Pharmacological inhibitors were used such as Wortmannin, Bay 11-7082, Genistein, GF109203X, PD98059, SB203580, SP600125, and U-73122 (Cell Signaling Technology, Danvers, MA) for the inhibition of phosphoinositide 3-kinase (PI3K), IkB-[alpha] phosphorylation, protein tyrosine kinase (PTK), protein kinase C (PKC), MEK1, sApK2 (p38), jun N-terminal kinase (JNK), and phospholipase C (PLC), respectively.
2.8. Mice Immunization and ELISA. Five-week-old female BALB/c mice were intranasally immunized three times with 10 [micro]L of PBS containing oval albumin (OVA) as an antigen alone or in combination with PMA or FlaB at 7-day intervals. Seven days after the last immunization, feces and serum samples were collected from the immunized mice to assess antigen-specific antibody responses. All animal procedures were conducted in accordance with the guidelines of the Animal Care and Use Committee of Chonnam National University. OVA-specific antibodies were determined by ELISA followed-by the methods as described elsewhere . Absorbance was read by an ELISA microplate reader (Power Wavex340, NIO-TEK-INS TRUMENTS, INC) at 450 nm.
2.9. Cytokine Assay in Splenocytes from Vaccinated Mice. Spleen lymphocytes were prepared from the immunized mice by using lymphoprep according to the manufacturer's instructions (AXIS-SHIELD PoC AS, Norway). The lymphocytes were cultured in RPMI 1640 medium containing 10% FBS, 100U/mL penicillin, and 100 [micro]g/mL streptomycin and incubated with OVA (10 [micro]g/mL) at 37[degrees]C for 2 days. The levels of interleukin 12 (IL-12) were measured by using sandwich ELISA kits following the manufacturer's experimental protocols (Biolegend, USA).
2.10. Statistical Analysis. All values are expressed as means [+ or -] standard error of the mean (SEM). Statistical comparisons were made using Student's t-test. All experiments were repeated three times and the results from a representative experiment were shown.
3. Results and Discussion
3.1. Croton tiglium and Its Chloroform Fraction Induced NF-[kappa]B Transcription in TLR5-Independent Pathway and Enhanced FlaB Activity. TLR5 recognizes bacterial flagellin and activates a transcription factor NF-[kappa]B hence inducing proinflammatory cytokine production in mammalian cells . We studied to identify herbal medicines that enhanced NF-[kappa]B activity of a flagellin, FlaB. TLR5 and NF-[kappa]B-SEAP were overexpressed in HEK293T cells by transfection with the plasmids and a plant extract library was screened. The 90% EtOH extract from Croton tiglium increased NF-[kappa]B transcription in HEK293T cells in TLR5-independent pathway and enhanced the FlaB activity inducing TLR5-dependent NF-[kappa]B activation (Figure 1(a)). To identify active components of Croton tiglium, the 90% EtOH crude extract was divided into 5 fractions: n-hexane, chloroform, ethyl acetate, n-butanol, and water layers. The chloroform fraction showed a more significant effect than the other fractions on NF-[kappa]B activity at concentrations of 30~300 ng/mL (Figure 1(b)).
3.2. Structure Determination and Identification of Active Component Inducing NF-[kappa]B Activation from Croton tiglium. In order to isolate an active component, the chloroform fraction from Croton tiglium extract was subjected to a succession of chromatographic procedures including silica gel chromatography, RP-[C.sub.18], and HPLC (Figure 2(a)). Each fraction was tested on NF-[kappa]B transcription in HEK293T cells and the activities were shown in Table 1. When phorbol 12-myristate-13-actate [PMA; synonym: 12-O-tetradecanoylphorbol-13-actate (TPA)] from Sigma Co. (St. Louis, USA) and an isolated compound (Compound 1) were coinjected into HPLC, the same retention time ([t.sub.R]) at 31.3 min suggested that it was an identical compound (Figure 2(b)). For further confirmation of the chemical structure of isolated compound, [sup.1]H and [sup.13]C NMR (nuclear magnetic resonance) spectra of 1 were measured on a Varian Unity Inova 600 MHz spectrometer at the Korea Basic Science Institute (KBSI, Gwangju Center, Korea). The [sup.1]H and [sup.13]C NMR spectroscopic data of Compound 1 showed the characteristic signals for an [alpha], [beta]-unsaturated carbonyl group [([[delta].sub.H] 7.57, 1H, br s, H-1; [[delta].sub.C] 160.7, C-1); [[delta].sub.C] 132.8, C-2; [[delta].sub.C] 208.8, C-3], a trisubstituted double bond [([[delta].sub.H] 5.66, 1H, d, 7 = 4.6 Hz, H-7; [[delta].sub.C] 129.2, C-7); [[delta].sub.C] 140.4, C-6], an oxymethine ([[delta].sub.H] 5.39, 1H, d, 7 = 10.1 Hz, H-12; [[delta].sub.C] 76.5, C-12), and an oxymethylene [[[delta].sub.H] 4.01 and 4.00, AB 2H, 7 = 12.8 Hz, [H.sub.2]-20; [[delta].sub.C] 68.0, C-20] of a phorbol ester system [15,16]. As the NMR and MS data [m/z 616.3980, Micromass QTOF2 (Micromass, Wythenshawe, UK)] are identical with those reported for PMA [16, 17], Compound 1 was finally determined as PMA (Figure 2(c)).
Compound 1. Colorless oil; [sup.1]H (600 MHz, in CD[Cl.sub.3]): [[delta].sub.H] 7.57 (1H, br s, H-1), 5.66 (1H, d, J = 4.6 Hz, H-7), 5.51 (1H, br s, OH-9), 5.39 (1H, d, J = 10.1 Hz, H-12), 4.01 and 4.00 (2H, AB peaks, J = 12.8 Hz, H2-20), 3.23 (1H, br s, H-10), 3.21 (1H, t, J = 5.5 Hz, H-8), 2.52 and 2.46 (2H, AB peaks, J = 19.3 Hz, H-5), 2.30 (2H, m, H-2'), 2.12 (1H, m, H-11), 2.07 (3H, s, acetyl), 1.76 (3H, dd, J = 2.7,1.4 Hz, H-19), 1.60 (2H, m, H-3'), 1.18-1.31 [26, (4'-13' methylene) and 2 x methyl (H-16 and H 17) ], 1.06 (1H, d, J = 5.0 Hz, H-14), 0.87 (3H, d, J = 6.4 Hz, H 18), 0.86 (3H, t, J = 6.5 Hz, H-14'); [sup.13]C NMR data (150 MHz, in CD[Cl.sub.3]): [[delta].sub.C] 160.7 (C-1), 132.8 (C-2), 208.8 (C-3), 73.7 (C-4), 38.6 (C-5), 140.4 (C-6), 129.2 (C-7), 39.1 (C-8), 78.1 (C-9), 56.2 (C-10), 42.9 (C-11), 76.5 (C-12), 65.6 (C-13), 36.2 (C-14), 25.6 (c-15) 23.8 (c-16), 16.8 (C-17), 14.1 (c-18), 10.1 (C-19), 68.0 (c-20), 173.7 (C-1'), 34.6 (C-2'), 25.2 (C-3'), 29.0-29.6 (C-4' to C-11'), 31.9 (C-12'), 22.7 (C-13'), 14.1 (C-14'), 173.7 and 21.1 (acetyl); EIMS m/z 616.3980 (calcd for [C.sub.36][H.sub.56][O.sub.8], 616.3975).
3.3. PMA Increased Significantly FlaB-Mediated NF-[kappa]B Activity and IL-8 Production in TLR5-IndependentPathway. PMA, an active component of Croton tiglium, was evaluated whether it could stimulate FlaB-mediated NF-[kappa]B activity and IL-8 production. PMA at a low concentration of 10 ng/mL increased NF-[kappa]B activity with or without FlaB (20 ng/mL) (Figure 3(a)). PMA also enhanced significantly FlaB-mediated IL-8 production in Caco-2 cells expressing TLR5 constitutively (Figure 3(b)). These results suggest that PMA is an active component of Croton tiglium in NF-[kappa]B transactivation.
3.4. PMA Induced the Translocation of NF-[kappa]B from Cytosol into Nucleus. Like other members of the NF-[kappa]B family, p65 resides in the cytoplasm in an inactive form bound to inhibitory I[kappa]B protein. Cellular activation results in the nuclear translocation of p50:p65 for initiating gene transcription. We therefore assessed the nuclear translocation of NF-[kappa]B p65 subunit after its activation by PMA treatment (10 ng/mL) to the HEK293T cells by immunostaining. NF-[kappa]B p65 was translocated from cytosol to nucleus after PMA treatment (Figure 4(a)).
3.5. A PKC Inhibitor Blocked PMA-Induced NF-[kappa]B Activation in HEK293T Cells. To study the action mechanism of PMA, various pharmacological inhibitors were tested on PMA-mediated NF-[kappa]B activation. Two hours after inhibitor incubation, the cells were treated with PMA at a concentration of 10 ng/mL. The supernatants were collected after 1 day of PMA treatment and NF-[kappa]B-SEAP levels were determined by QUANTI-Blue. PMA-induced NF-[kappa]B activation was blocked by the treatment of a PKC inhibitor GF109203X and an I[kappa]B-[alpha] degradation inhibitor Bay11-7082 (Figure 4(b)). These results indicate that PMA induces NF-[kappa]B activation through PKC-dependent I[kappa]B phosphorylation.
3.6. PMA Increased OVA-Specific Systemic Immune Response in Mice. BALB/c mice were intranasally immunized three times with antigen OVA alone or in combination with FlaB or PMA under anesthesia. Seven days after immunization, feces and serum samples were collected from the immunized mice to assess antigen-specific antibody responses. OVA-specific IgA and IgG antibodies were significantly increased by the administration of OVA plus PMA or FlaB (Figure 5(a)). These results suggest that PMA has vaccine adjuvant activity.
3.7. PMA Increased IL-12 Production in Spleen Lymphocytes of Vaccinated Mice. Spleen lymphocytes were prepared by using lymphoprep from vaccinated mice and cytokines were analyzed by ELISA. IL-12 production was significantly increased in spleen lymphocytes isolated from OVA-vaccinated mice treated with PMA (Figure 5(b)).
4. Conclusion and Discussion
The present study demonstrates the vaccine adjuvant effect of PMA isolated from Croton tiglium. To identify herbal medicines potentiating the vaccine adjuvant effect of flagellin, a plant library was screened using HEK293T cells transiently cotransfected with phTLR5 and pNF-[kappa]B-SEAP plasmids. Because HEK293T cells do not express any TLRs, the cells transfected with phTLR5 plasmid DNA were used for TLR5dependent response in the absence of other TLRs. Flagellin, a TLR5 agonist, activated a transcription factor NF-[kappa]B only in the presence of TLR5 (Figure 1). In contrast, the 90% EtOH extract of Croton tiglium and its chloroform layer significantly stimulated NF-[kappa]B transcription both in TLR5- and TLR5+ screening systems (Figure 1). PMA was isolated and characterized as an active component from Croton tiglium (Figure 2) by activity-guided fractionation, column chromatography, HPLC, NMR, and MS. PMA induced NF-[kappa]B transactivation in a TLR5-independent manner and increased IL-8 production in Caco-2 cells constituently expressing some TLRs (Figure 3). These results indicate that PMA is not a specific ligand for TLR5. The effect of PMA was dependent on NF-[kappa]B translocation and PKC activation (Figure 4(b)). Finally, PMA or FlaB enhanced antigen-specific IgG and IgA antibody responses in intranasally OVA-immunized mice (Figure 5(a)). In addition, PMA increased IL-12 production corresponding to T cell responses (Figure 5(b)). The present study suggests that PMA activating PKC of TLR signaling pathway has a possibility for being an efficacious mucosal vaccine adjuvant.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
Dool-Ri Oh and Hu Won Kang contributed equally to this paper. Young Ran Kim, Joon Haeng Rhee, and Won Keun Oh participated in research design. Dool-Ri Oh, Hu Won Kang, and Jong-Ro Kim conducted experiments. Young Ran Kim, Sunoh Kim, and In-Kyu Park performed data analysis. Young Ran Kim, Dool-Ri Oh, and Hu Won Kang wrote or contributed to the writing of the paper.
This work was supported by Basic Science Research Program (no. NRF-2012R1A1A2038900) through the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology by the Grant (no. RTI05-0101) from the Regional Technology Innovation Program of the Ministry of Knowledge Economy (MKE) and by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A120899).
 S. Akira and H. Hemmi, "Recognition of pathogen-associated molecular patterns by TLR family," Immunology Letters, vol. 85, no. 2, pp. 85-95, 2003.
 M. Schnare, G. M. Barton, A. C. Holt, K. Takeda, S. Akira, and R. Medzhitov, "Toll-like receptors control activation of adaptive immune responses," Nature Immunology, vol. 2, no. 10, pp. 947-950, 2001.
 S. Akira, S. Uematsu, and O. Takeuchi, "Pathogen recognition and innate immunity" Cell, vol. 124, no. 4, pp. 783-801, 2006.
 R. Medzhitov, "Recognition of microorganisms and activation of the immune response," Nature, vol. 449, no. 7164, pp. 819-826, 2007.
 J. H. Rhee, S. E. Lee, and S. Y. Kim, "Mucosal vaccine adjuvants update," Clinical and Experimental Vaccine Research, vol. 1, no. 1, pp. 50-63, 2012.
 S. Akira, K. Takeda, and T. Kaisho, "Toll-like receptors: critical proteins linking innate and acquired immunity," Nature Immunology, vol. 2, no. 8, pp. 675-680, 2001.
 F. Hayashi, K. D. Smith, A. Ozinsky et al., "The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5," Nature, vol. 410, no. 6832, pp. 1099-1103, 2001.
 S. B. Mizel, A. N. Honko, M. A. Moors, P. S. Smith, and A. P. West, "Induction of macrophage nitric oxide production by gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes," Journal of Immunology, vol. 170, no. 12, pp. 6217-6223, 2003.
 S. E. Lee, S. Y. Kim, B. C. Jeong et al., "A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity," Infection and Immunity, vol. 74, no. 1, pp. 694-702, 2006.
 C. T. Nguyen, S. H. Hong, J. I. Sin et al., "Flagellin enhances tumor-specific [CD8.sup.+] T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model," Vaccine, vol. 31, no. 37, pp. 3879-3887, 2013.
 C. Y. Hong, S. Y. Kim, H. J. Lee et al., "A bacterial flagellin in combination with proinflammatory cytokines activates human monocyte-derived dendritic cells to generate cytotoxic t lymphocytes having increased homing signals to cancer," Journal of Immunotherapy, vol. 37, no. 1, pp. 16-25, 2014.
 X. Wang, M. Lan, H.-P. Wu et al., "Direct effect of croton oil on intestinal epithelial cells and colonic smooth muscle cells," World Journal of Gastroenterology, vol. 8, no. 1, pp. 103-107, 2002.
 K.-I. Morimura, "The role of special group article in ancient chinese medical prescription," Historia Scientiarum, vol. 13, no. 1, pp. 1-12, 2003.
 J.-C. Tsai, S. Tsai, and W.-C. Chang, "Effect of ethanol extracts of three Chinese medicinal plants with laxative properties on ion transport of the rat intestinal epithelia," Biological and Pharmaceutical Bulletin, vol. 27, no. 2, pp. 162-165, 2004.
 X. L. Zhang, L. Wang, F. Li et al., "Cytotoxic phorbol esters of Croton tiglium," Journal of Natural Products, vol. 76, no. 5, pp. 858-864, 2013.
 L. A. C. Pieters and J. Vlietinck, "[sup.13]C NMR spectroscopy of phorbol esters," Magnetic Resonance in Chemistry, vol. 25, pp. 368-374, 1987.
 G. Vogg, S. Achatz, A. Kettrup, and H. Sandermann Jr., "Fast, sensitive and selective liquid chromatographic-tandem mass spectrometric determination of tumor-promoting diterpene esters," Journal of Chromatography A, vol. 855, no. 2, pp. 563-573, 1999.
Dool-Ri Oh (1), Hu Won Kang (1), Jong-Ro Kim (2), Sunoh Kim (1), In-Kyu Park (3), Joon Haeng Rhee (4), Won Keun Oh (5), and Young Ran Kim (6)
(1) Jeollanamdo Institute of Natural Resources Research, Jangheung, Jeollanamdo 529-851, Republic of Korea
(2) Korea INSPharm Inc. 1065, Dong-myeon, Hwasun, Jeollanamdo 519-882, Republic of Korea
(3) Department of Biomedical Science and BK21 PLUS Center for Creative Biomedical Scientists, Chonnam National University Medical School, Gwangju 501-757, Republic of Korea
(4) Clinical Vaccine R&D Center, Chonnam National University Medical School, Gwangju 501-757, Republic of Korea
(5) Korea Bioactive Natural Material Bank, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea
(6) Department of Pharmaceutical Engineering, Dongshin University, Naju, Jeollanamdo 520-724, Republic of Korea
Correspondence should be addressed to Won Keun Oh; email@example.com and Young Ran Kim; firstname.lastname@example.org
Received 4 January 2014; Revised 31 March 2014; Accepted 1 April 2014; Published 18 May 2014
Academic Editor: Seong-Gyu Ko
TABLE 1: Effects of fractions from Croton tiglium on NF-[kappa]B transactivation. Fractions (10 ng/mL) Absorbance Fr.1 0.084 [+ or -] 0.004 Fr.2 0.094 [+ or -] 0.008 Fr.3 0.086 [+ or -] 0.004 Fr.4 0.071 [+ or -] 0.004 Fr.5 0.112 [+ or -] 0.001 Fr.6 0.121 [+ or -] 0.002 Fr.7 0.975 [+ or -] 0.086 Fr.8 0.991 [+ or -] 0.026 Fr.9 0.110 [+ or -] 0.003 Fr.10 0.068 [+ or -] 0.003 Fractions (3 ng/mL) Absorbance Fr.81 0.121 [+ or -] 0.002 Fr.82 0.132 [+ or -] 0.003 Fr.83 0.121 [+ or -] 0.003 Fr.84 0.124 [+ or -] 0.006 Fr.85 0.125 [+ or -] 0.004 Fr.86 0.223 [+ or -] 0.008 Fr.87 0.981 [+ or -] 0.035 Fr.88 0.631 [+ or -] 0.016 Fr.89 0.462 [+ or -] 0.036 Fractions (1 ng/mL) Absorbance Fr.871 0.080 [+ or -] 0.006 Fr.872 0.082 [+ or -] 0.004 Fr.873 0.120 [+ or -] 0.008 Fr.874 0.092 [+ or -] 0.004 Fr.875 0.077 [+ or -] 0.004 Fr.876 0.103 [+ or -] 0.000 Fr.877 0.318 [+ or -] 0.086 Fr.878 0.230 [+ or -] 0.026
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Research Article|
|Author:||Oh, Dool-Ri; Kang, Hu Won; Kim, Jong-Ro; Kim, Sunoh; Park, In-Kyu; Rhee, Joon Haeng; Oh, Won Keun; K|
|Publication:||Mediators of Inflammation|
|Date:||Jan 1, 2014|
|Previous Article:||Lancemaside a from Codonopsis lanceolata modulates the inflammatory responses mediated by monocytes and macrophages.|
|Next Article:||Lipid isolated from a Leishmania donovani strain reduces Escherichia coli induced sepsis in mice through inhibition of inflammatory responses.|